Key facts
- This page summarizes Hobart Kalkstein's Form 4 filing for CABOT CORP (CBT).
- 10 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2024, 17:00.
Hobart Kalkstein - 08 Nov 2024 Form 4 Insider Report for CABOT CORP (CBT)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- CBT
- Reported as of
- 08 Nov 2024
- Net transaction value
- -$2,935,232
- SEC form
- 4
- Accepted by SEC
- 13 Nov 2024, 17:00:09 UTC
- Prior SEC filing
- 02 Oct 2024
- Next SEC filing
- 20 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- By: Jennifer Lombardi, pursuant to a power of attorney from Hobart C. Kalkstein
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Hobart Kalkstein filed Form 4 for CABOT CORP (CBT) on 13 Nov 2024.
Change
- Previous filing in this sequence was filed on 02 Oct 2024.
- Current net transaction value: -$2,935,232.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CBT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,130
- Change %
- +5.1%
- Price
- $0.000000
- Shares after
- 64,818
- Date
- 08 Nov 2024
- Ownership
- Direct
CBT
transaction
Common Stock
Sale
- Transaction value
- $1,639,688
- Shares
- -14,191
- Change %
- -22%
- Price
- $115.54
- Shares after
- 50,627
- Date
- 11 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
CBT
transaction
Common Stock
Options Exercise
- Transaction value
- $709,612
- Shares
- +12,178
- Change %
- +24%
- Price
- $58.27
- Shares after
- 62,805
- Date
- 11 Nov 2024
- Ownership
- Direct
CBT
transaction
Common Stock
Sale
- Transaction value
- $1,400,481
- Shares
- -12,178
- Change %
- -19%
- Price
- $115.00
- Shares after
- 50,627
- Date
- 11 Nov 2024
- Ownership
- Direct
- Footnotes
- F2
CBT
transaction
Common Stock
Options Exercise
- Transaction value
- $619,518
- Shares
- +8,390
- Change %
- +17%
- Price
- $73.84
- Shares after
- 59,017
- Date
- 11 Nov 2024
- Ownership
- Direct
CBT
transaction
Common Stock
Sale
- Transaction value
- $965,014
- Shares
- -8,390
- Change %
- -14%
- Price
- $115.02
- Shares after
- 50,627
- Date
- 11 Nov 2024
- Ownership
- Direct
- Footnotes
- F3
CBT
transaction
Common Stock
Tax liability
- Transaction value
- $259,180
- Shares
- -2,303
- Change %
- -4.5%
- Price
- $112.54
- Shares after
- 48,324
- Date
- 12 Nov 2024
- Ownership
- Direct
CBT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,163
- Date
- 08 Nov 2024
- Ownership
- Through the Trustee for the Corporation's 401(k) Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CBT
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +9,341
- Change %
- Price
- $0.000000
- Shares after
- 9,341
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,341
- Exercise price
- $114.99
- Footnotes
- F4
CBT
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -12,178
- Change %
- -60%
- Price
- $0.000000
- Shares after
- 8,119
- Date
- 11 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,178
- Exercise price
- $58.27
- Footnotes
- F5
CBT
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -8,390
- Change %
- -60%
- Price
- $0.000000
- Shares after
- 5,594
- Date
- 11 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,390
- Exercise price
- $73.84
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.500 to $115.595, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
Footnote F2
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.040, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
Footnote F3
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.325, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
Footnote F4
The option vests over a three year period as follows: 30% on November 8, 2025, 30% on November 8, 2026 and 40% on November 8, 2027.
Footnote F5
20,297 shares were subject to the option. The option vested over a three year period as follows: 30% on November 12, 2022, 30% on November 12, 2023 and 40% on November 12, 2024.
Footnote F6
13,984 shares were subject to the option. The option vested over a three year period as follows: 30% on November 11, 2023, 30% on November 11, 2024 and 40% on November 11, 2025.